TABLETS COMPRISING CANDESARTAN CILEXETIL

ORAL PHARMACEUTICAL COATED COMPOSITION FOR PULSATILE RELEASE

ORALLY DISINTEGRATING TABLET COMPOSITIONS OF RANITIDINE AND METHODS OF MANUFACTURE

Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom

Cefuroxime axetil granule and process for the preparation thereof

Zolpidem pharmaceutical compositions

Immediate disintegration polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof

Lipoic acid pellets

Orally disintegrating tablet compositions of lamotrigine

NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS

Extended release venlafaxine formulation

Enterically coated cystamine, cysteamine and derivatives thereof

Release-control composition

Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration

Drug formulations having inert sealed cores

Pellet formulation for the treatment of the intestinal tract

Microspheres comprising nanocapsules containing a lipophilic drug

Controlled release tamsulosin hydrochloride formulation

Particulate Compositions Comprising Alginate and/or Alginic Acid

Pulsatile release histamine H2 antagonist dosage form

Duloxetine Formulation

Abuse resistant drug formulation

AMORPHOUS DRUG BEADS

Ginger Fraction For Inhibiting Human Cyp Enzymes

Dosage forms for movement disorder treatment

Orally disintegrable tablets

Formulations with Controlled Release of Active Ingredient

Pharmaceutical Compositions Comprising Danazol

Process for producing pharmaceutical composition

Compositions and methods for inhibiting gastric acid secretion

PHARMACEUTICAL COMPOSITIONS OF DULOXETINE

Enteric Coated Azithromycin Multiparticulates

Encapsulation Of Lipid-Based Formulations In Enteric Polymers

Taste masked dosage form containing roflumilast

Morphine Sulfate Formulations

Formulations With Controlled Release Of Active Ingredient

Extended-release dosage form

Sustained-release formulations of topiramate

Sustained release tamsulosin formulations

Encapsulated Nanoparticles for Drug Delivery

Modified Release For Proton Pump Inhibitors

Coated compositions and methods for preparing same

Drug Delivery Systems Comprising Solid Solutions of Weakly Basic Drugs

Prolonged-release multimicroparticulate oral pharmaceutical form

Particulate form of a pharmaceutical composition which is easy to swallow

DIVALPROEX PHARMACEUTICAL COMPOSITIONS

Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors

Pharmaceutical form having a two-layer separating layer

Phenylephrine pharmaceutical formulations and compositions for colonic absorption

Duloxetine hydrochloride delayed release formulations

Enteric coated granule and method for preparing the same

ORALLY DISINTEGRATING DOSAGE FORMS

Colonic drug delivery formulation

Oral dosage forms including an antiplatelet agent and an acid inhibitor

Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof

NON-HOMOGENOUS DOSAGE FORM COATINGS

Controlled Release Pharmaceutical Composition Comprising An Acid-Insoluble And A Bioadhesive Polymer

Formulations for a tight junction effector

Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same

TASTE MASKED PHARMACEUTICAL PARTICLES

Taste-masked drugs in rupturing multiparticulates

ENTERIC-COATED PREPARATION COVERED WITH ENTERIC COATING MATERIAL FOR SITE-SPECIFIC DELIVERY OF DRUG TO SITE WITHIN THE SMALL INTESTINE

Coating process to produce controlled release coatings

Pharmaceutical composition and process

Latex or pseudolatex compositions, coatings and coating processes

Oral ribavirin pharmaceutical compositions

Oral ribavirin pharmaceutical compositions

Encapsulation of lipid-based formulations in enteric polymers

Delayed release carnitine

Controlled release formulation of divalproex sodium

Coating method

Gastric release pulse system for drug delivery

Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors

Modified Release Formulation of Lithium Carbonate and Method for Preparation Thereof

Dosage forms for movement disorder treatment

Delayed release pancreatin compositions

Process for the manufacture and use of pancreatin micropellet cores

Pharmaceutical composition

Orally administrable extended release pellet and tablet formulations of a highly water soluble compound

Extended release osmo-microsealed formulation

Multi-layered coating technology for taste masking

Water Soluble and Palatable Complexes

Stable lansoprazole formulation

Probiotic composition having acid-resistant enteric coating

High drug load mesalazine sachet

Sachet for a pharmaceutical composition

Treatment of allergic conditions

Acid labile drug compositions

Oral pharmaceutical delivery system with improved sustained release

Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these

Dosage forms for movement disorder treatment

Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof

Timed, pulsatile release systems

Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability

Flavored taste-masked pharmaceutical formulation made using a one-step coating process

Controlled release compositions of gamma-hydroxybutyrate

Use of film coating as taste-masking coating of oral dosage forms

Dual controlled release dosage form

Dosage form and method for sustained release of substituted pyrazine compound

Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)

Stable pharmaceutical composition comprising an active substance in the form of solid solution

Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor

Method and composition for stable and controlled delivery of (-)-hydroxycitric acid

Microspheres and related processes and pharmaceutical compositions

Anti-microbial composition using in-situ generation of an oxidizing agent

Less abusable pharmaceutical preparations

Method of providing customized drug delivery systems

Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof

Pharmaceutical compositions containing venlafaxine

Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects

Microcapsules for stabilization of cosmetic, pharmaceutical or food products

Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration

Delayed release carnitine

Controlled release preparation

Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition

Abuse-deterrent drug formulations

Resorbable matrices with coatings for delivery of bioactive compounds

Therapeutic calcium phosphate particles and methods of making and using same

Orally disintegrating tablets and methods of manufacture

Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist

Treating or preventing restless legs syndrome using prodrugs of GABA analogs

Abuse-resistant pharmaceutical dosage form

Sustained release tamsulosin formulations

Compositions and methods for timed release of a water-soluble nutritional supplement, methylsulfonylmethane

Compositions and methods for timed release of water-soluble nutritional supplements

Method for normalizing insulin levels

Coated drug delivery formulations

Method of treatment for improved bioavailability

Biodegradable oxidized cellulose esters and their uses as microspheres

Extended release venlafaxine formulation

Extended release formulations of opioids and method of use thereof

Antibiotic product, use and formulation thereof

Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

Antibiotic product, use and formulation thereof

Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration

Enteric-coated proliposomal formulations for poorly water soluble drugs

Pulsatile release histamine H2 antagonist dosage form

Functional powders for oral delivery

Extended-release pharmaceutical compositions of Ralinepag

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics